Technology
Health
Pharmaceutical

Odonate Therapeutics

$33.17
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.06%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ODT and other stocks, options, ETFs, and crypto commission-free!

About ODT

Odonate Therapeutics, Inc. Common Stock, also called Odonate Therapeutics, is a pharmaceutical company, which engages in the development of therapeutics that improves and extends the lives of patients with cancer. Read More It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The company was founded in March 2013 and is headquartered in San Diego, CA.

Employees
130
Headquarters
San Diego, California
Founded
2013
Market Cap
887.38M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
154.13K
High Today
$33.33
Low Today
$32.12
Open Price
$32.91
Volume
121.02K
52 Week High
$37.99
52 Week Low
$11.54

Collections

Technology
Health
Pharmaceutical
Therapy
Cancer Prevention
2017 IPO
US
North America

ODT Earnings

-$1.24
-$1.09
-$0.94
-$0.79
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 25, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.